JPRN-UMIN000012198招募中未知
The effects of insulin Degludec on glucose fluctuation in patients with type 1 diabetes - The effects of insulin Degludec on glucose fluctuation in patients with type 1 diabetes
Division of Diabetes, Department of Internal Medicine, Diabetes Center,Aichi Medical University0 个研究点目标入组 20 人开始时间: 2013年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with hypersensitivity to Degludec 2)Patients with severe renal or liver failure 3)Patients with proliferative diabetic retinopathy (except for stable condition by photocoagulation) 4)Patients who are pregnant or in lactation period 5)Patients who achieve good plasma glucose levels by treatment with insulin Glargine 6)Judged as ineligible by clinical investigators
研究者
相似试验
招募中
不适用
The effects of insulin Degludec on glucose fluctuation in patients with type 2 diabetestype 2 diabetesJPRN-UMIN000012199Division of Diabetes, Department of Internal Medicine, Diabetes Center,Aichi Medical University20
已完成
不适用
The efficacy of insulin degludec on plasma glucose control in diabetes mellitusType 2 diabetes mellitusJPRN-UMIN000011333Internal Medicine 1, Shimane University Faculty of Medicine40
进行中（未招募）
不适用
The effect of insulin degludec in combination with liraglutide and metformin in subjects with type 2 diabetes qualifying for treatment intensificatioMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersDiabetes Mellitus, Type 2EUCTR2011-004665-32-GBovo Nordisk A/S320
进行中（未招募）
不适用
The effect of insulin degludec in combination with liraglutide and metformin in subjects with type 2 diabetes qualifying for treatment intensification.Diabetes Mellitus Type 2MedDRA version: 15.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-004665-32-ITOVO NORDISK320
进行中（未招募）
不适用
The effect of insulin degludec in combination with liraglutide and metformin in subjects with type 2 diabetes qualifying for treatment intensificatioDiabetes Mellitus, Type 2EUCTR2011-004665-32-DEovo Nordisk A/S320